Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study
- 20 August 2022
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 174, 134-141
Abstract
No abstract availableKeywords
Funding Information
- Roche
This publication has 24 references indexed in Scilit:
- Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?Molecular Endocrinology, 2015
- Childbearing attitudes and decisions of young breast cancer survivors: a systematic reviewHuman Reproduction Update, 2013
- Is Letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?Gynecological Endocrinology, 2013
- How do chemotherapeutic agents damage the ovary?Human Reproduction Update, 2012
- Toxicity of Chemotherapy and Radiation on Female ReproductionClinical Obstetrics & Gynecology, 2010
- Progesterone induces adult mammary stem cell expansionNature, 2010
- A quantitative assessment of follicle size on oocyte developmental competenceFertility and Sterility, 2008
- Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled StudyJournal of Clinical Oncology, 2008
- Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before ChemotherapyThe Journal of Clinical Endocrinology & Metabolism, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006